CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial

CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial

Show other versions (1)

<h4>Background</h4> Filter clotting is a major issue in continuous kidney replacement therapy (CKRT) that interrupts treatment, reduces delivered effluent dose, and increases cost of care. While a number of variables are involved in filter life, treatment modality is an understudied fact...

Full description

Bibliographic Details
Main Authors: Lewis Mann, Patrick Ten Eyck, Chaorong Wu, Maria Story, Sree Jenigiri, Jayesh Patel, Iiro Honkanen, Kandi O’Connor, Janis Tener, Meenakshi Sambharia, Mony Fraer, Lama Nourredine, Douglas Somers, Jonathan Nizar, Lisa Antes, Sarat Kuppachi, Melissa Swee, Elizabeth Kuo, Chou-Long Huang, Diana I. Jalal, Benjamin R. Griffin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833553/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833553/?tool=EBI

Similar Items